4//SEC Filing
Bruff Jesse Michael 4
Accession 0001127602-20-030399
CIK 0000203527other
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 3:18 PM ET
Size
31.0 KB
Accession
0001127602-20-030399
Insider Transaction Report
Form 4
Bruff Jesse Michael
SVP Finance, CFO
Transactions
- Exercise/Conversion
Common Stock
2020-12-01$131.77/sh+5,716$753,197→ 8,691 total - Exercise/Conversion
Common Stock
2020-12-01$146.91/sh+10,087$1,481,881→ 15,790 total - Exercise/Conversion
Common Stock
2020-12-01$107.32/sh+10,465$1,123,104→ 14,142 total - Tax Payment
Common Stock
2020-12-01$174.19/sh−9,291$1,618,399→ 6,499 total - Exercise/Conversion
Non Qualified Stock Option (Right to Buy)
2020-12-01−10,087→ 0 totalExercise: $146.91Exp: 2027-02-13→ Common Stock (10,087 underlying) - Tax Payment
Common Stock
2020-12-01$174.19/sh−2,936$511,422→ 2,791 total - Exercise/Conversion
Common Stock
2020-12-01$99.26/sh+3,750$372,225→ 5,727 total - Tax Payment
Common Stock
2020-12-01$174.19/sh−851$148,236→ 2,975 total - Tax Payment
Common Stock
2020-12-01$174.19/sh−5,014$873,389→ 3,677 total - Tax Payment
Common Stock
2020-12-01$174.19/sh−8,439$1,469,989→ 5,703 total - Exercise/Conversion
Non Qualified Stock Option (Right to Buy)
2020-12-01−3,750→ 0 totalExercise: $99.26Exp: 2024-08-17→ Common Stock (3,750 underlying) - Exercise/Conversion
Common Stock
2020-12-01$112.82/sh+1,035$116,769→ 3,826 total - Exercise/Conversion
Non Qualified Stock Option (Right to Buy)
2020-12-01−10,465→ 0 totalExercise: $107.32Exp: 2026-08-15→ Common Stock (10,465 underlying) - Exercise/Conversion
Non Qualified Stock Option (Right to Buy)
2020-12-01−1,035→ 0 totalExercise: $112.82Exp: 2025-02-08→ Common Stock (1,035 underlying) - Exercise/Conversion
Non Qualified Stock Option (Right to Buy)
2020-12-01−5,716→ 0 totalExercise: $131.77Exp: 2026-02-14→ Common Stock (5,716 underlying)
Footnotes (10)
- [F1]Represents shares withheld for payment of exercise price of $99.26 per share as well as payment of federal, state and payroll taxes due on settlement
- [F10]Per agreement executed on 24 November 2020, vesting on all outstanding stock option shares has been accelerated. Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option originally vested as follows: one third on February 13, 2021, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.
- [F2]Represents shares withheld for payment of exercise price of $112.82 per share as well as payment of federal, state and payroll taxes due on settlement
- [F3]Represents shares withheld for payment of exercise price of $131.77 per share as well as payment of federal, state and payroll taxes due on settlement
- [F4]Represents shares withheld for payment of exercise price of $107.32 per share as well as payment of federal, state and payroll taxes due on settlement
- [F5]Represents shares withheld for payment of exercise price of $146.91 per share as well as payment of federal, state and payroll taxes due on settlement
- [F6]Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 8/17/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.
- [F7]Per agreement executed on 24 November 2020, vesting on all outstanding stock option shares has been accelerated. Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option originally vested as follows: one third on February 8, 2019, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.
- [F8]Per agreement executed on 24 November 2020, vesting on all outstanding stock option shares has been accelerated. Stock option granted under the Varian Medical Systems, Inc. Fifth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option originally vested as follows: one third on February 14, 2020, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.
- [F9]Per agreement executed on 24 November 2020, vesting on all outstanding stock option shares has been accelerated. Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The options originally vested as follows: one third on 8/15/2020, and the remaining shares in 24 equal installments over the 24 months following the first vesting date.
Documents
Issuer
VARIAN MEDICAL SYSTEMS INC
CIK 0000203527
Entity typeother
Related Parties
1- filerCIK 0001795741
Filing Metadata
- Form type
- 4
- Filed
- Dec 2, 7:00 PM ET
- Accepted
- Dec 3, 3:18 PM ET
- Size
- 31.0 KB